Filing Details
- Accession Number:
- 0001209191-22-033336
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-01 21:32:38
- Reporting Period:
- 2022-05-31
- Accepted Time:
- 2022-06-01 21:32:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1408443 | Milestone Pharmaceuticals Inc. | MIST | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1120362 | F Paul Truex | C/O Milestone Pharmaceuticals Inc. 1111 Dr. Frederik-Philips Blvd, Ste 420 Montr?Al A8 H4M 2X6 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-05-31 | 8,016 | $1.12 | 8,016 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2022-05-31 | 45,072 | $1.54 | 53,088 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2022-05-31 | 22,870 | $1.54 | 75,958 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2022-05-31 | 822 | $2.66 | 76,780 | No | 4 | M | Direct | |
| Common Shares | Acquisiton | 2022-05-31 | 5,000 | $5.60 | 81,780 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares | Stock Option (right to buy) | Disposition | 2022-05-31 | 8,016 | $0.00 | 8,016 | $1.12 |
| Common Shares | Stock Option (right to buy) | Disposition | 2022-05-31 | 45,072 | $0.00 | 45,072 | $1.54 |
| Common Shares | Stock Option (right to buy) | Disposition | 2022-05-31 | 22,870 | $0.00 | 22,870 | $1.54 |
| Common Shares | Stock Option (right to buy) | Disposition | 2022-05-31 | 822 | $0.00 | 822 | $2.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-08-26 | No | 4 | M | Direct | |
| 0 | 2027-07-21 | No | 4 | M | Direct | |
| 2,659 | 2028-10-15 | No | 4 | M | Direct | |
| 117 | 2028-11-20 | No | 4 | M | Direct |
Footnotes
- Fully vested and exercisable.
- Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Billionaire Hedge Funds
